Metabolic Activation and Inactivation of Irinotecan When Combined With the Human Monoclonal Antibody Bevacizumab. J. Anal. Oncol. 2013, 2 (4),  218-225. https://doi.org/10.6000/1927-7229.2013.02.04.4.